Form 4: American Oncology Network CEO Todd Schonherz Acquires Additional Shares

Todd Schonherz, CEO of American Oncology Network, recently purchased shares of the company's Class A Common Stock.

Summary

• On May 21, 2024, Todd Schonherz, the CEO of American Oncology Network, Inc. (AONC), acquired shares of Class A Common Stock.
• He purchased 4,000 shares at $1.87 each, 1,000 shares at $1.85 each, and 340 shares at $1.86 each.
• Following these transactions, Schonherz directly owns 5,340 shares of Class A Common Stock.
• He also indirectly owns 869,459 shares of Class B Common Stock through the Schonherz Family Trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CEO purchasing shares is generally a good sign, but the quantity is relatively small.

Positives

• The CEO's purchase of shares could be interpreted as a positive signal about his confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. Investors often monitor these filings to gain insights into management's sentiment about the company's stock.

Stakeholder Impact

• The CEO's stock purchase could positively influence shareholder sentiment.

Key Dates

Keywords

AONC, American Oncology Network, Todd Schonherz, SEC Form 4, Beneficial Ownership, Stock Acquisition, Insider Trading